Skip Links

Download centre

  • Full Annual Report 2009 English (PDF 5.8 Mb)
  • Introduction (PDF 1.8 Mb)
  • Our year in brief (PDF 318 Kb)
  • Chairman's Statement (PDF 86 Kb)
  • CEO's Review (PDF 100 Kb)
  • AstraZeneca at a glance (PDF 276 Kb)
  • Path to a new medicine (PDF 180 Kb)
  • Directors' Report (PDF 2.6 Mb)
  • Business Environment (PDF 236 Kb)
  • Strategy and Performance (PDF 116 Kb)
  • Resources, Skills and Capabilities (PDF 6.4 Mb)
  • Financial Review (PDF 256 Kb)
  • Geographical Review (PDF 92 Kb)
  • Therapy Area Review (PDF 616 Kb)
  • Other Businesses (PDF 40 Kb)
  • Environmental Sustainability (PDF 132 Kb)
  • In the Global Community (PDF 48 Kb)
  • Risk (PDF 116 Kb)
  • Business Organisation and Corporate Governance (PDF 1.1 Mb)
  • Directors' Remuneration Report (PDF 424 Kb)
  • Financial Statements (PDF 1.7 Mb)
  • Additional Information (PDF 945 Kb)
  • Development Pipeline (PDF 56 Kb)
  • Shareholder Information (PDF 64 Kb)
  • Corporate Information (PDF 40 Kb)
  • Cross-reference to Form 20-F (PDF 44 Kb)
  • Glossary (PDF 52 Kb)
  • Contact Information (PDF 44 Kb)
  • Full Annual Report 2009 Swedish (PDF 3.3 Mb)
  • Introduction (PDF 708 Kb)
  • Directors' Report (PDF 1.7 Mb)
  • Financial Statements (PDF 760 Kb)
  • Additional Information (PDF 224 Kb)

Back to top

Strategy and
Performance

"The executive team ... believes that the most value-creating strategy for AstraZeneca is to remain a focused, integrated, innovation-driven, global, prescription-based biopharmaceutical business."

Find out more

Quick
links

Download
Report

AstraZeneca Annual Report and Form 20-F Information 2009

English (PDF 5.8Mb)
Swedish (PDF 3.3Mb)

Visit the Download centre